CAS No – 214766-78-6

Status – Pre-Valdation

Product Description

Degarelix is a gonadotropin-releasing hormone (GnRH) receptor antagonist used to treat advanced prostate cancer. It works by blocking the effects of GnRH, which reduces the production of testosterone, a hormone that can fuel prostate cancer growth. Degarelix is administered as an injection and is available under the brand name Firmagon.